Record Quarterly Revenues
Achieved revenues of $150 million, up 10% year-over-year, marking the highest quarterly revenues ever in core products and services.
Significant EBITDA Growth
EBITDA increased by 26% to $11.7 million from $9.3 million, with the EBITDA margin expanding by a full percentage point to 7.8%.
Healthcare Apparel and Branded Products Growth
Healthcare Apparel and Branded Products both saw 11% revenue growth compared to the previous year.
Improved Financial Strength
Generated positive operating cash flow, improved net leverage ratio, and reduced debt from $94 million at year-end 2023 to $85 million.
Successful Share Repurchase
Repurchased approximately 452,000 shares for $6.3 million, with $3.7 million remaining under the buyback authorization.